Clinical Trials
Showing 1167 Clinical Trials-
Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children
Start Date: August 2022 Updated: October 2016
Ketamine
Phase 4
Completed
-
Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)
Start Date: August 2022 Updated: March 2014
Salt Lake City, Utah, USAGHB
Phase 1|Phase 2
Completed
-
Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults
Start Date: August 2022 Updated: March 2010
Vienna, AustriaGHB
Phase 1
Completed
-
Sodium Oxybate in the Treatment of Binge Eating Disorder
Start Date: August 2022 Updated: June 2011
Mason, Ohio, USAGHB
Phase 2|Phase 3
Completed
-
A Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia
Start Date: August 2022 Updated: December 2011
Austin, Texas, USA
Houston, Texas, USA
Sacramento, California, USA
San Antonio, Texas, USA
Santa Barbara, California, USA
Salt Lake City, Utah, USA
Eugene, Oregon, USA
Indianapolis, Indiana, USA
Phoenix, Arizona, USA
Durham, North Carolina, USA
Winston-Salem, North Carolina, USA
Charleston, South Carolina, USA
Pasadena, California, USA
Santa Ana, California, USA
Peoria, Illinois, USA
Lexington, Kentucky, USA
Lansing, Michigan, USA
Omaha, Nebraska, USA
Charlotte, North Carolina, USA
Oklahoma City, Oklahoma, USA
Greer, South Carolina, USA
Chattanooga, Tennessee, USA
Madisonville, Kentucky, USA
Springfield, Massachusetts, USA
Berlin, New Jersey, USA
Columbus, Ohio, USA
Fort Worth, Texas, USA
Rochester, New York, USA
Orlando, Florida, USA
Albany, New York, USA
St. Louis, Missouri, USA
Springfield, Missouri, USA
Fort Lauderdale, Florida, USA
Worcester, Massachusetts, USA
Edison, New Jersey, USA
Bowling Green, Kentucky, USA
Raleigh, North Carolina, USA
Anniston, Alabama, USA
Renton, Washington, USA
Anaheim, California, USA
Pismo Beach, California, USA
Fort Meyers, Florida, USA
Mechanicsburg, Pennsylvania, USA
Carmichael, California, USA
Plantation, Florida, USA
Gurnee, Illinois, USA
Cherry Hill, New Jersey, USA
Mogadore, Ohio, USA
Tulsa, Oklahoma, USA
Warwick, Rhode Island, USA
Knoxville, Tennessee, USA
Kirkland, Washington, USA
Charleston, West Virginia, USA
Burbank, California, USA
Largo, Florida, USA
Westfield, New York, USA
Evansville, Indiana, USA
Huntsville, Alabama, USA
Whittier, California, USA
Port Orange, Florida, USA
Middletown, Ohio, USA
Perrysburg, Ohio, USA
Medford, Oregon, USAGHB
Phase 3
Completed
-
Xyrem for Treatment Refractory Insomnia Due to PTSD
Start Date: August 2022 Updated: September 2012
Syracuse, New York, USAGHB
Phase 2
Withdrawn
-
Physiological, Behavioral and Subjective Effects of Drugs (GHB)
Start Date: August 2022 Updated: September 2008
Baltimore, Maryland, USAGHB
Phase 1
Completed
-
Exploratory Study of Low Dose Psilocybin
Start Date: August 2022 Updated: May 2022
Psilocybin
Early Phase 1
Not yet recruiting
-
Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Start Date: August 2022 Updated: February 2022
MDMA
Phase 2
Withdrawn
-
Psilocybin-facilitated Treatment for Chronic Pain
Start Date: August 2022 Updated: May 2022
Psilocybin
Early Phase 1
Not yet recruiting